Stock AnalizCareTrust REIT, Inc. CTRE
Real Estate Investment Trusts · IPO 2022 · data as of November 13, 2026
CareTrust REIT, Inc. (CTRE) is a real estate company listed in the US with a market value of about $9.8B. In the twelve months to September 30, 2026 it had revenue of $615M and net income of $364M, a net margin of 59.2%.
Its overall Stock Analiz score is 3.0 out of 5 (average). The strongest part is future growth (4/5); the weakest is value (2/5).
Key numbers: a P/E of 23.8, a price to free cash flow of 20.2, 5-year revenue growth of 22% a year, a 5-year average ROIC of 3%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 83% above the current price.
Score: 3.0 / 5
Checks passed
- P/E below 25
- Price below intrinsic value (DCF, moderate assumptions)
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
- Strong R&D investment or growth above 20%
- 5-year EPS growth above 10% a year
- 5-year revenue growth above 8% a year
Checks not passed
- P/E below the industry median
- P/FCF below 20
- PEG below 1.5
- 3-year free cash flow growth above 10% a year
- 5-year average ROIC above 12%
- Profitable 5 years in a row
- ROE above 15%
- More cash than debt, or low debt to equity
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $615M | $476M | $296M | $218M | $196M | $192M | $178M | $163M | $157M | $133M | $105M |
| Net income | $364M | $321M | $125M | $54M | -$8M | $72M | $81M | $46M | $58M | $26M | $29M |
| Free cash flow | $485M | — | — | — | — | — | — | $123M | $98M | $88M | $64M |
| EPS (diluted) | $1.60 | $1.57 | $0.80 | $0.50 | $-0.08 | $0.74 | $0.85 | $0.49 | $0.72 | $0.35 | $0.52 |
| Net margin | 59.2% | 67.3% | 42.2% | 24.7% | -3.8% | 37.4% | 45.4% | 28.4% | 36.9% | 19.5% | 28.0% |
| ROIC | — | 5.4% | 3.6% | 2.9% | 0.2% | 4.1% | 4.4% | 2.4% | 3.5% | 1.5% | 2.4% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 14 analysts is $43.57, 14% above the current price; targets range from $41.00 to $47.00; the consensus rating is “Buy”; expected EPS is $1.71 for the fiscal year ending December 31, 2026.
Frequently asked questions
What is CareTrust REIT’s P/E ratio?
About 23.8, based on the last twelve months of diluted earnings per share (forward P/E about 20.5).
Is CareTrust REIT stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 83% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does CareTrust REIT pay a dividend?
Yes. The dividend yield is about 4.10%, and it has paid dividends for 10 years in our data.
Is CareTrust REIT a good stock to buy?
We do not give buy or sell advice. CareTrust REIT scores 3.0 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.